Thursday, November 21, 2024
Home Tags Miti

Tag: miti

Mitesco
Research

Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165%...

Editor / Curator -
All News

Good Clinic Owned by Mitesco (MITI) In Star Tribune.

Editor / Curator -
Incubator

Mitesco’s (MITI) CEO Featured In Yahoo News Video.

Editor / Curator -
Good Clinic, Biotech Stock Review
Biotech News

Mitesco (MITI) $0.45 to Open its First Medical Clinic.

Editor / Curator -
Mitesco, Biotech Stock Review, roland rick perry
2020 Watch List

Short Squeeze Mania.

Editor / Curator -
Biotech News

Make Hay While the Sun Shines. Up 6,400%.

Editor / Curator -
All News

Mitesco (MITI) Expands ‘The Good Clinic’ to Colorado.

Editor / Curator -
Telehealth

Mitesco Inc. Initiates “The Good Clinic” Rollout in Minneapolis; Introduces the...

Editor / Curator -
Institutional Analyst Newsletter

2020 Biotech Portfolio Soars 55%, We’re Amazed. Next Up: The Coming...

Editor / Curator -
Telehealth

How CoronaVirus Accelerated the Rise of Telemedicine (CNBC). Telehealth.

Editor / Curator -
1234Page 1 of 4

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.